Lynx1 Capital Management’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,902,434
| Closed | -$7.06M | – | 25 |
|
|
2023
Q2 | $7.06M | Buy |
3,902,434
+578,373
| +17% | +$1.05M | 4.63% | 7 |
|
|
2023
Q1 | $4.39M | Buy |
3,324,061
+320,959
| +11% | +$424K | 3.66% | 9 |
|
|
2022
Q4 | $5.08M | Buy |
3,003,102
+727,370
| +32% | +$1.23M | 4.39% | 8 |
|
|
2022
Q3 | $4.21M | Buy |
2,275,732
+95,172
| +4% | +$176K | 3.8% | 7 |
|
|
2022
Q2 | $6.69M | Buy |
2,180,560
+537,726
| +33% | +$1.65M | 5.7% | 6 |
|
|
2022
Q1 | $11.9M | Buy |
1,642,834
+1,241,241
| +309% | +$8.96M | 11.01% | 4 |
|
|
2021
Q4 | $6.57M | Buy |
+401,593
| New | +$6.57M | 5.74% | 6 |
|